Rodis D Paparodis
Overview
Explore the profile of Rodis D Paparodis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simeakis G, Kapama A, Paparodis R, Gkousis P, Koursaros P, Kokkinis C, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002668
Structural incomplete response (SIR) (persistence/recurrence) may occur in 2-6% of low-risk differentiated thyroid cancer (DTC)-cases and in 67-75% of high risk. Regarding locoregional disease, surgery is the optimal therapeutic modality...
2.
Angelopoulos N, Paparodis R, Androulakis I, Boniakos A, Livadas S
Nutrients
. 2025 Feb;
17(3).
PMID: 39940277
Background/objectives: Vitamins D and B12 play a crucial role in maintaining bone health, immune function, and neurological integrity. Combined deficiencies in these vitamins can lead to severe health consequences. Current...
3.
Livadas S, Angelopoulos N, Kollias A, Paparodis R, Androulakis I, Anagnostis P, et al.
J Endocrinol Invest
. 2025 Feb;
PMID: 39899246
Purpose: Levothyroxine (LT4) is commonly prescribed, but there is evidence strongly suggesting that a significant proportion of these patients are on treatment without solid evidence of hypothyroidism. Small trials on...
4.
Paparodis R, Bantouna D, Livadas S, Angelopoulos N
Curr Atheroscler Rep
. 2024 Dec;
27(1):21.
PMID: 39738779
Purpose Of Review: Atherosclerotic cardiovascular disease (ASCVD) is one of the most common causes of death globally and the leading one in the US. Elevated low-density lipoprotein (LDL) cholesterol is...
5.
Myerson M, Paparodis R
J Clin Pharmacol
. 2024 Jun;
64(10):1204-1221.
PMID: 38924121
Obesity is a disease of epidemic proportions in the United States and contributes to morbidity and mortality for a large part of the population. In addition, the financial costs of...
6.
Myerson M, Paparodis R, Block R, Karalis D, Mintz G, Brinton E, et al.
J Clin Lipidol
. 2024 Jun;
18(4):e488-e500.
PMID: 38908968
Polycystic ovary syndrome (PCOS) is a common endocrinopathy worldwide with a heterogeneous clinical presentation including reproductive, metabolic, and endocrine elements. However, the assessment and management of PCOS remains inconsistent, with...
7.
Papanikos V, Papadodima E, Bantouna D, Paparodis R, Livadas S, Angelopoulos N, et al.
Clin Pract
. 2024 Feb;
14(1):179-187.
PMID: 38391401
Background: Parathyroid adenoma is the most common cause of hypercalcemia and rarely leads to a hypercalcemic crisis, which is an unusual endocrine emergency that requires timely surgical excision. Case Presentation:...
8.
Paparodis R, Bantouna D, Karvounis E, Zoupas I, Livadas S, Angelopoulos N, et al.
Nutrients
. 2024 Jan;
16(1).
PMID: 38201941
Background: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (<30 ng/mL-VDD). We designed the present real-world study to assess this paradox....
9.
Gitsi E, Livadas S, Angelopoulos N, Paparodis R, Raftopoulou M, Argyrakopoulou G
Nutrients
. 2023 Dec;
15(23).
PMID: 38068755
Achieving optimal glucose control in individuals with type 1 diabetes (T1DM) continues to pose a significant challenge. While continuous insulin infusion systems have shown promise as an alternative to conventional...
10.
Angelopoulos N, Paparodis R, Androulakis I, Anagnostis P, Boniakos A, Duntas L, et al.
Thyroid Res
. 2023 Jul;
16(1):18.
PMID: 37455308
Background: In the last decade, the combination of the widespread use of streptavidin-biotin technology and biotin-containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous...